← Evidence map

ReviewDrug safety2019

Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer.

Iosune Baraibar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

57 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 30649742